DNAY - Codex DNA, Inc. Stock Price, Fair Value and News

$2.98-0.19 (-5.99%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DNAY Price Action

Last 7 days

23.6%

Last 30 days

-2.1%

Last 90 days

-11.4%

Trailing 12 Months

231.7%

DNAY RSI Chart

DNAY Valuation

Market Cap

5.9M

Price/Earnings (Trailing)

-0.13

Price/Sales (Trailing)

0.41

EV/EBITDA

-0.2

Price/Free Cashflow

-0.25

DNAY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DNAY Fundamentals

DNAY Revenue

Revenue (TTM)

14.4M

Rev. Growth (Yr)

-71.85%

Rev. Growth (Qtr)

1.03%

DNAY Earnings

Earnings (TTM)

-45.6M

Earnings Growth (Yr)

37.52%

Earnings Growth (Qtr)

47.22%

DNAY Profitability

Operating Margin

47.15%

EBT Margin

-308.71%

Return on Equity

167.33%

Return on Assets

-184.14%

Free Cashflow Yield

-399.12%

DNAY Investor Care

Buy Backs (1Y)

94.08%

Diluted EPS (TTM)

-12.24

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	23.8M	18.4M	14.4M	0
2023	28.1M	29.5M	28.4M	26.7M
2022	14.4M	17.2M	21.0M	27.4M
2021	7.7M	8.8M	9.9M	11.0M
2020	0	0	0	6.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Codex DNA, Inc.

WEBSITE	https://codexdna.com

Codex DNA, Inc. Frequently Asked Questions

What is the ticker symbol for Codex DNA, Inc.? What does DNAY stand for in stocks?

DNAY is the stock ticker symbol of Codex DNA, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Codex DNA, Inc. (DNAY)?

As of Thu Oct 31 2024, market cap of Codex DNA, Inc. is 5.95 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DNAY stock?

You can check DNAY's fair value in chart for subscribers.

Is Codex DNA, Inc. a good stock to buy?

The fair value guage provides a quick view whether DNAY is over valued or under valued. Whether Codex DNA, Inc. is cheap or expensive depends on the assumptions which impact Codex DNA, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DNAY.

What is Codex DNA, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Oct 31 2024, DNAY's PE ratio (Price to Earnings) is -0.13 and Price to Sales (PS) ratio is 0.41. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DNAY PE ratio will change depending on the future growth rate expectations of investors.